A new study finds black women with chronic pain experience higher levels of disability, post-traumatic stress disorder, and emotional impairment compared to white women. The research emphasizes the need for improved access to quality pain care and a better understanding of minority patients' needs.
Researchers found that endomorphin 1, a natural painkiller, had no effect on chronic arthritis pain. The study suggests the need for alternative pain management strategies for long-term arthritis sufferers.
A study found that expectations about pain can significantly affect its intensity. Participants who expected lower levels of pain reported a 28% decrease in pain ratings compared to those who expected higher levels. This suggests that the brain plays a crucial role in shaping the perception of pain.
A new study provides direct evidence that the brain's own pain-fighting chemicals play a role in the placebo effect, reducing feelings of pain. Participants who received a sham pain treatment reported increased activity in their mu opioid endorphin system after being told they were receiving a medicine.
A study of 5,364 patients found that knee pain is often accompanied by pain in other joints, leading to poorer general and psychological health. The results suggest that managing pain in one region can have beneficial effects on overall perception of pain.
A randomised trial found that a brief pain management programme delivered by physiotherapists was as effective as a package of physiotherapy incorporating spinal manual-therapy techniques in treating low back pain. The programme resulted in fewer treatment sessions and referrals to secondary care.
A recent study found that fibromyalgia patients' level of depression has little impact on their intensity of pain experience, suggesting that treatments for each condition should be considered separately. Researchers hope that separating these two complex conditions can lead to more effective pain management.
Researchers studied brain activity in fibromyalgia patients to understand depression-pain connection. They found heightened sensitivity to pressure-induced pain in FM patients, regardless of depressive symptoms. The study suggests treating depression and physical pain separately for better outcomes.
Researchers used fMRI to study brain activity under hypnosis for pain suppression, finding reduced activity in pain network areas and increased activity in other regions. This suggests that hypnosis blocks the pain signal from reaching the brain's perception centers.
A virtual reality game has been found to significantly reduce pain responses in children with severe burns, with all but one child showing a decrease of at least 2 points on the Faces Scale. The game was more effective than analgesics alone in reducing pain and anxiety.
A recent study sheds light on the disparities in pain care faced by minority groups, including African Americans and Hispanics. The research reveals that these individuals often receive inadequate pain management, contributing to worse health outcomes.
A study by researchers at Michigan Medicine and the University of South Florida found a significant generation gap in chronic pain coping among black and white adults. Older adults generally scored higher on pain intensity and disability measurements, but younger adults experienced more depression symptoms and sleep disturbances.
Chronic pain is classified as a disease due to its definition in the Oxford English dictionary and persistence beyond initial symptoms. The financial costs of chronic pain are significant, comparable to those of cancer and heart disease.
Researchers at Brown Medical School and Quality Partners tested a rapid-cycle quality improvement model to address persistent pain in nursing home residents. The study showed a significant reduction in pain, with 44% of homes using appropriate pain assessments and 82% using non-drug pain treatments.
A study published in The Journal of Neuroscience found that chronic back pain is associated with a significant decrease in gray matter volume in the brain, particularly in regions involved in processing information and memory. This suggests that proper treatment may reverse some of the brain changes caused by chronic pain.
DepoDur offers a safe and effective alternative to traditional epidural analgesia, providing up to 48 hours of effective pain control without the need for continuous infusion. This single-shot epidural formulation has been shown to improve treatment of postoperative pain following major surgery.
A retrospective study found that low-dose ketamine infusions provided complete relief from CRPS pain for 76% of patients, with 54% remaining pain-free for three months or more. The therapy's effectiveness was linked to its ability to block NMDA-receptor complexes involved in pain processing.
Women with vulvodynia process pain differently, exhibiting lower pain tolerance at multiple sites throughout the body. The study suggests a neurological basis for the condition, recommending treatment aimed at central pain processing.
Researchers found that virtual reality significantly reduces pain-related brain activity, with drops of up to 97%. The study used specialized magnetic resonance imaging to track brain activity and showed a significant change in conscious perception of pain when virtual reality was used.
A new clinical trial demonstrates that treating migraine with Relpax during mild pain provides greater efficacy than waiting for pain to become more severe. Patients who treated early experienced significantly higher two-hour pain-free rates compared to those who waited.
Researchers followed patients with no initial back pain and found that those with poor coping skills, chronic pain, or disputed workers' compensation claims were nearly three times more likely to develop back pain. The study suggests that treating psychological factors may be a more effective approach than surgery for some patients.
A recent study published in The Journal of Pain found that women are more sensitive to pain than men, while African-Americans and Whites report similar levels of pain when using standardized rating scales. Researchers tested 135 participants aged 25-45 and used modified rating scales to account for cultural differences.
A study by Casa Colina Centers for Rehabilitation found that elderly patients experienced decreased pain intensity and improved sleep disturbances with once-daily Kadian dosing. The trial, KRONUS-MSP, showed a lower incidence of side effects compared to other opioids, making it an ideal option for managing chronic pain in older adults.
A Mayo Clinic study of 100 patients with advanced pancreatic cancer found that a nerve block technique, combined with pain-relieving medications, provided a 50% reduction in pain and improved quality of life. The study suggests that this treatment option could be beneficial for patients with pancreatic cancer, allowing them to live mor...
A new study published in the journal Pain found that people with depression are four times more likely to develop intense or disabling neck and low back pain. Researchers hope to uncover why these conditions are commonly linked, exploring coping methods to break a vicious cycle.
A UCL study found that empathy for pain involves the affective but not sensory components of pain, and is triggered by the perception of a loved one's pain. The researchers discovered specific brain regions are activated when observing another person in pain, highlighting the emotional representation of internal bodily states.
A study found that hospitalized patients experience significant pain levels, with 59% reporting pain, and that certain characteristics like age, sex, and diagnosis can identify high-risk patients. In contrast, no clear predictors were identified for low-risk patients, suggesting that all hospitalized patients may be at high risk for pain.
Researchers found that 3% of women report chronic pain and 1.7% currently have pain, affecting millions across the US. The study also revealed that African-American women are as likely to experience vulvodynia as Caucasian women.
The guidelines recommend five medication types to treat neuropathic pain, including gabapentin, lidocaine patches, and narcotics. Neuropathic pain affects 4-6 million people in the US, caused by nerve damage from conditions like shingles, diabetes, and cancer.
Scientists have discovered that touch input plays a crucial role in guiding the normal maturation of the pain sensitivity system during development, contradicting the long-held assumption that it is an innate process. This finding has important implications for understanding chronic pain and may lead to new therapeutic methods.
A study published in the American Journal of Managed Care found that guideline-based cancer pain management offers effective pain relief in 80% of patients compared to 30% effectiveness for non-specialty providers. The targeted approach ensures a pre-determined treatment plan, reducing variability and increasing patient outcomes.
A new Duke study finds that forgiveness, through loving-kindness meditation, reduces back pain and depression in patients with persistent low back pain. The study suggests a strong relationship between forgiveness and pain, including measures of adjustment.
A study found racial and ethnic disparities in pain perception, diagnosis, and treatment across various specialties. Disparities were seen in emergency departments, cancer clinics, chronic pain, and disability, with African Americans and Hispanics facing unequal access to pain medication and treatment.
Researchers investigated chronic pain management through surveys, questionnaires, and studies. The results highlighted the importance of pain treatment outcomes, associations with health-risk behaviors, and post-traumatic stress disorder relationships. Additionally, a new exercise program improved arm and hand recovery after stroke.
A study found that patients with unexplained chronic fatigue had nine times more prevalent sinus symptoms than the control group, and six times more common in those with unexplained chronic pain. Sinusitis may be a contributing factor to chronic fatigue syndrome in some cases.
Researchers have identified a new compound, AM1241, that acts on CB2 cannabinoid receptors and shows promise in alleviating neuropathic pain. The study suggests that this compound may provide pain relief without the debilitating side effects of existing pharmaceuticals.
Researchers found that stimulating a small region of the cerebral cortex, known as the rostral agranular insular cortex (RAIC), can diminish pain in patients with chronic pain conditions. Increasing GABA levels in this area produced analgesia up to 10 days, suggesting a novel target for therapy.
Researchers used MRI to assess brain function while participants experienced heat stimuli. People who reported higher pain levels showed increased activation in key brain areas, such as the primary somatosensory cortex and anterior cingulate cortex. This confirms the importance of self-reports in guiding pain treatment.
A study by Michael DeBaun and colleagues found that children with neuropathic pain require significantly higher doses of morphine and benzodiazepine than those without. Using methadone as an alternative, the team discovered a more effective treatment approach for pain relief in these patients.
A recent study found that most women (72%) experience some level of pain during mammography, but this does not deter them from returning for follow-up screening. The study also discovered a link between the timing of mammograms and pain levels in premenopausal women.
A new study published in The Lancet has found that laparoscopic adhesiolysis does not provide substantial pain relief or improvement in quality of life for patients with adhesions and chronic abdominal pain. The study recommends abandoning this procedure as a treatment option.
A study of 81 undergraduates found that males exhibit higher pain thresholds and tolerances than females. The researchers also discovered that psychological factors can influence the association between physiological responses and pain responses, and additional research is needed to replicate these findings.
A new study found that levorphanol's ability to reduce pain is comparable to tricyclic antidepressants and gabapentin, commonly used drugs for neuropathic pain treatment. High-dose treatment provided greater pain reduction without tolerance, but also led to more side effects and participant dropout.
African Americans with chronic pain experience significantly more symptoms than whites when seeking treatment, including greater levels of pain, depression, and impairment. Economic factors also play a significant role in producing these disparities.
A new study finds Keppra alleviates severe nerve pain in cancer patients by reducing VAS scores to 0-3 within 3-14 days, with a significant decrease in opioid use. The medication was well-tolerated and showed potential therapeutic benefits for further investigation.
A community study of 400 patients with various pain types found that Keppra was well-tolerated and provided significant pain relief. The medication was effective in treating a range of conditions, including migraine headaches, nerve pain, and diabetic pain.
A study of 141 whiplash patients and 40 ankle injury patients found that whiplash pain was more frequent but similar in intensity to ankle injuries. Pain improved significantly over time, with most patients returning to work within a year.
Researchers found that individuals with two copies of the met form of the COMT gene had a more pronounced response to pain, while those with two copies of the val form reported less pain and fewer negative emotions. The study used PET brain imaging and controlled jaw pain to investigate the role of genetic variation in pain tolerance.
A study published in the American Association for the Advancement of Science suggests that estrogen levels influence women's ability to suppress pain. The researchers used PET scans to examine the brain's response to pain in individuals with different gender, hormone, and genetic profiles.
A Stanford study found a significant link between depression and chronic pain, suggesting that pain may guide doctors to effective treatments for depressed patients. The research also indicates that continuous pain increases the likelihood of major depressive disorder diagnosis.
A brain study reveals that people with lower back pain experience severe pain even from a gentle finger squeeze, while fibromyalgia patients feel the same level of pain. The study uses fMRI to measure brain activity and finds enhanced response to pain in some areas and diminished response in others.
A recent survey of 968 women aged 15-59 found that nearly 60% were told their pain is normal by their Ob/Gyn or a friend/family member. Chronic pelvic pain affects many lives, but often takes years to receive an accurate diagnosis.
The Mayo Clinic study highlights the effectiveness of opioids in relieving chronic lower back pain, despite controversy over misuse and potential drug dependence. The research emphasizes the need for careful patient selection and close monitoring to ensure safe treatment outcomes.
Researchers at McGill University are studying sex-associated pain in women, focusing on the issue of pain itself rather than its physical or psychological causes. They recommend a combination of cognitive behavioral pain management and physical therapy for relief.
Dr. James Henry studies the electrical activity of nerve cells to understand how pain is transmitted to the brain. He hopes to establish collaborations among pain researchers and medical professionals to improve treatment options for patients suffering from chronic pain.
Neuropathic pain is a complex condition that can be difficult to treat, but research suggests that psychological factors play a crucial role. Dr. Bushnell's work highlights the importance of catching pain early and treating it aggressively, as well as exploring alternative approaches such as meditation and drawing
A new study reveals that rats with chronic pain from inflammation were more tolerant of painful heat stimuli and had less swelling when fed a diet based on soy protein. The findings suggest that a soy diet may reduce the need for opioid medications, which are often associated with severe side effects.
The Center for the Study of Pharmacologic Plasticity in the Presence of Pain at Wake Forest will study changes in the spinal cord caused by certain medicines and their impact on pain sensation. The research aims to develop new, effective pain treatments for patients with nerve injury or neuropathic pain.
Breakthrough pain in cancer patients incurs $12,000/year in medical services; non-breakthrough patients incur $2,400/year. Study finds link between breakthrough pain and increased need for hospitalizations, emergency room visits, and doctor visits.
A genetic mechanism involved in pain modulation has been discovered, which could lead to an entirely new approach to pain control. Genetically engineered mice lacking the DREAM gene showed dramatic loss of pain sensitivity compared to those with the gene.